Climedo

Climedo is a Munich-based startup, founded in 2017, that offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. The company's patient-centric approach and real-time data insights empower clients in the Health Care and Pharmaceutical industries to better engage with healthcare professionals and key opinion leaders (KOLs). With over 1.7 million patients enrolled to date, Climedo has positioned itself as a trusted partner for pharma, medtech, CROs, and academia. In its last investment round on 16 February 2022, Climedo secured a €5.00M Seed Round investment from Nauta Capital, WestTech Ventures, and Prof. Dr. med. Christian Wallwiener. The company's slogan, "The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization," underscores its focus on streamlining post-approval trials and accelerating the commercialization of medical innovations to reach more patients faster.